Dermatology

Projects

Projects per year 2000 2007 2010 2013 2014 2015 2016 2017 2018 2019 2020 2022 2028

• 36 Active
• 93 Finished

Projects per year

Search results

• Finished

  Resident Leadership Academy in Health Equity: a pilot curriculum for a nationwide program in addressing health disparities in dermatology

  Jacobsen, A. A.

  AMERICAN ACADEMY OF DERMATOLOGY

  5/1/22 → 1/27/23

  Project: Research project

  • Health 100%
  • Health Disparity 100%
  • Resident 100%
  • Dermatology 100%

• Developing the next generation of safer 2-in-1 hair dye products

  Bigliardi, P. L.

  NATIONAL UNIVERSITY OF SINGAPORE

  12/1/19 → 3/31/22

  Project: Research project

  • Hair Dye 100%
  • Chemical Reaction Product 100%

• The Impact of Pediatric Skin Disorders: The "Big" Study

  Boull, C. L.

  NORTHWESTERN UNIVERSITY, REGENERON PHARMACEUTICALS, INC.

  9/13/19 → 12/31/20

  Project: Research project

  • Pediatrics 100%
  • Dermatosis 100%
  • Skin Disease 100%

• A Multi-center Study to Evaluate the Pharmacokinetics ofDiacerein and Rhein and the Safety of Diacerein after MaximumUse, Topical Administration of CCP-020 (Diacerein 1%ointment) to Patients with Epidermolysis Bullosa (EB)

  Hook, K. P.

  CASTLE CREEK PHARMACEUTICALS, LLC

  1/21/19 → 7/31/19

  Project: Research project

  • Rhein 100%
  • Diacerein 100%
  • Epidermolysis bullosa 100%
  • Pharmacokinetics 100%

• An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)

  Hook, K. P.

  CASTLE CREEK PHARMACEUTICALS, LLC

  1/1/19 → 7/31/19

  Project: Research project

  • Epidermolysis Bullosa Simplex 100%
  • Diacerein 50%

• Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficay of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma

  Bohjanen, K. A.

  SOLIGENIX INC

  11/27/18 → 5/6/22

  Project: Research project

  • Placebo-Controlled Study 100%
  • Hypericin 100%
  • Irradiation 100%
  • Cutaneous T Cell Lymphoma 100%
  • Blindness 100%

• Intergrated Behavioral Healthcare in Dermatology: A C-Located Care Pilot Study.

  Hordinsky, M. K. & Berge, J. M.

  UNIVERSITY OF WISCONSIN-STOUT, NATIONAL ALOPECIA AREATA FOUNDATION

  10/1/18 → 9/30/19

  Project: Research project

  • Pilot Study 100%

• Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-monthOpenlabelFollow-up of Oleogel-S10 in Patients with Inherited Epidermolysis Bullosa

  Hook, K. P.

  AMRYT RESEARCH, LTD

  8/30/18 → 8/30/23

  Project: Research project

  • Epidermolysis bullosa 100%

• WEN Shampoo Study

  Farah, R. S. & Hordinsky, M. K.

  CHAZ DEAN, INC.

  8/27/18 → 10/31/21

  Project: Research project

• A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study ofPatidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal CellCarcinomas (BCCs) in Subjects with Basal Cell Nevus

  Maher, I.

  PELLEPHARM, INC.

  8/27/18 → 8/31/23

  Project: Research project

  • Amaurosis 100%
  • Gorlin Syndrome 100%
  • Disease Burden 100%
  • Basal Cell Nevus Syndrome 100%
  • Blindness 100%

• Cutaneous T-Cell Lymphoma study

  Goyal-O'Leary, A.

  AMERICAN SOCIETY OF HEMATOLOGY

  7/1/18 → 9/30/19

  Project: Research project

  • Cutaneous T Cell Lymphoma 100%

• A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis

  Hordinsky, M. K.

  ACLARIS THERAPEUTICS, INC

  6/15/18 → 6/30/22

  Project: Research project

  • Placebo 100%
  • Tolerability 100%
  • Alopecia 100%
  • Alopecia Areata 100%
  • Blindness 100%

• An Open Label Extension Study to Assess the Long Term Safety and Efficacy of Dupilumab in Patients > 6months to < 18 years of age with Atopic Dermatitis

  Maguiness, S.

  REGENERON PHARMACEUTICALS, INC.

  11/1/17 → 11/30/22

  Project: Research project

  • Atopic Dermatitis 100%
  • Age 100%
  • Dupilumab 100%

• Epidermolysis Bullosa Clinical Characterization and Outc

  Hook, K. P. & Boull, C. L.

  EPIDERMOLYSIS BULLOSA MED RESEARCH FOUND

  8/24/17 → 6/30/18

  Project: Research project

  • Epidermolysis bullosa 100%
  • Data Base 50%

• An International, Multicenter, Randomized, Double-Blind,

  Hook, K. P.

  MEDPACE, INC.

  8/1/17 → 8/30/21

  Project: Research project

  • Blindness 100%
  • Epidermolysis Bullosa Simplex 50%
  • Diacerein 50%

• A Randomized, Double-blind, Vehicle-controlled

  Hordinsky, M. K.

  ACLARIS THERAPEUTICS, INC

  8/1/17 → 8/30/21

  Project: Research project

  • Blindness 100%
  • Tolerability 50%
  • Alopecia Areata 50%

• Characteristics of patients with mycosis fungoides/Sezar

  Goyal-O'Leary, A.

  AMERICAN SOCIETY OF HEMATOLOGY

  7/1/17 → 6/30/18

  Project: Research project

  • Patient 100%
  • Mycosis fungoides 100%
  • Oncology 50%
  • Hematology 50%
  • Patient Referral 50%

• A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,

  Hordinsky, M. K.

  PFIZER, INC.

  6/21/17 → 1/30/22

  Project: Research project

  • Placebo 100%
  • Blindness 100%
  • Alopecia Areata 100%

• Severity and Culture Status in Epidermolysis Bullosa wit

  Hook, K. P.

  PEDIATRIC DERMATOLOGY RESEARCH ALLIANCE

  3/1/17 → 12/31/19

  Project: Research project

  • Vinegar 100%

• A Phase 2/3 Study Investigation the Phamacokinetics, Saf

  Maguiness, S.

  REGENERON PHARMACEUTICALS, INC.

  2/1/17 → 2/28/23

  Project: Research project

  • Atopic Dermatitis 100%
  • Age 100%
  • Dupilumab 100%

• Program for Innovative Continuing Medical Education in D

  Hurliman, E. & Reich, H. C.

  AMERICAN ACADEMY OF DERMATOLOGY

  1/1/17 → 12/31/18

  Project: Research project

  • Program 100%
  • Continuing Medical Education 100%
  • Dermatology 50%

• Allogeneic skin grafting in the treatment of chronic

  Shih, T. L. & Miller, D. D.

  WOMEN'S DERMATOLOGIC SOCIETY

  7/15/16 → 7/14/19

  Project: Research project

  • Skin Transplantation 100%
  • Therapeutic Procedure 100%
  • Graft Versus Host Reaction 50%
  • Skin Graft 50%

• Cutaneous Findings in Fanconi Anemia and Patient Percept

  Boull, C. L., Hook, K. P., Maguiness, S. & Polcari, I. C.

  PEDIATRIC DERMATOLOGY RESEARCH ALLIANCE

  7/1/16 → 12/31/17

  Project: Research project

  • Patient 100%
  • Fanconi Anemia 100%
  • Skin 50%
  • Perception 50%

• Cannabinoid-based therapy and approaches to quantify pai

  Gupta, K., Bagchi, A., Connett, J. E., Datta, Y. H., Ericson, M. E., He, B., Honda, C. N., Simone, D. A. & Ugurbil, K.

  NATIONAL INSTITUTES OF HEALTH (NIH)

  6/1/16 → 5/31/19

  Project: Research project

  • Combination Therapy 100%
  • Cannabinoid 100%
  • Sickle-Cell Disease 50%
  • Pain 50%
  • Sickle Cell Anemia 50%

• An Open Label Multi-Center Extension Study to Evaluate

  Hook, K. P.

  SCIODERM, INC.

  4/22/16 → 4/30/20

  Project: Research project

  • Epidermolysis bullosa 100%

• A Phase 3, Multi-center, Randomized, Double-Blind

  Hook, K. P.

  SCIODERM, INC.

  4/20/16 → 4/30/20

  Project: Research project

  • Blindness 100%
  • Placebo-Controlled Study 50%
  • Epidermolysis bullosa 50%

• Multicenter, Randomized, Double-Blind Placebo-Controlled

  Hordinsky, M. K.

  ALLERGAN, INC

  3/1/16 → 3/30/21

  Project: Research project

  • Placebo 100%
  • Blindness 100%
  • Tablet 50%
  • Male Type Alopecia 50%
  • Setipiprant 50%

• Intralesional cidofovir for the treatment of recalcitran

  Polcari, I. C.

  THE SOCIETY FOR PEDIATRIC DERMATOLOGY

  10/22/15 → 4/21/17

  Project: Research project

  • Cidofovir 100%
  • Therapeutic Procedure 100%
  • Pediatrics 50%
  • Verruca Vulgaris 50%

• Skin Dendritic Cells and Humoral Immunity

  Jenkins, M. & Hordinsky, M. K.

  UNIVERSITY OF PITTSBURGH, NATIONAL INSTITUTES OF HEALTH (NIH)

  9/1/15 → 3/31/20

  Project: Research project

  • Skin 100%
  • Humoral Immunity 100%
  • Dendritic Cell 100%
  • Cellular Immunity 100%

• Epidermolysis Bullosa Clinical Characterization

  Hook, K. P.

  EB RESEARCH PARTNERSHIP, INC.

  8/5/15 → 6/30/17

  Project: Research project

  • Epidermolysis bullosa 100%

• An Open-Label (Part A) and a Double-Blind, Randomized, P

  Hordinsky, M. K.

  INCYTE CORPORATION

  8/1/15 → 8/30/20

  Project: Research project

  • Blindness 100%
  • Alopecia Areata 100%
  • Placebo 50%
  • Ruxolitinib 50%
  • Phosphate 50%

• Skin Dendritic Cells and Humoral Immunity

  Kaplan, D. H., Igyarto, B. Z. & Jenkins, M.

  NIH NIAMS NATL INST OF ARTHRIT

  4/6/15 → 8/31/15

  Project: Research project

  • Skin 100%
  • Humoral Immunity 100%
  • Dendritic Cell 100%
  • Cellular Immunity 100%

• A Randomized, Double-Blind, Placebo-Controlled Study of

  Bohjanen, K. A.

  XOMA CORPORATION

  1/1/15 → 12/31/18

  Project: Research project

  • Placebo-Controlled Study 100%
  • Blindness 100%
  • Ulcer 50%
  • Gevokizumab 50%
  • Pyoderma gangrenosum 50%

• A 2-Year, Open-Label, Safety Extension Study of Gevokizu

  Bohjanen, K. A.

  XOMA CORPORATION

  1/1/15 → 12/31/18

  Project: Research project

  • Gevokizumab 100%
  • Pyoderma 100%

• Keratinocytes Control Homeostatic and Inflammation-induc

  Shaik, J.

  AMERICAN SKIN ASSOCIATION

  1/1/15 → 1/1/15

  Project: Research project

  • Inflammation 100%
  • Keratinocyte 100%
  • Langerhans Cell 50%
  • Cell Migration 50%

• A Randomized, Double-Blind, Double-Dummy

  Bohjanen, K. A.

  GENENTECH, INC.

  12/17/14 → 12/16/18

  Project: Research project

  • Amaurosis 100%
  • Blindness 100%
  • Pemphigus vulgaris 100%
  • Rituximab 100%
  • Inpatient 50%

• EPIDERMOLYSIS BULLOSA CLINICAL CHARACTERIZATION AND OUTC

  Hook, K. P.

  EPIDERMOLYSIS BULLOSA MED RESEARCH FOUND

  10/1/14 → 12/31/15

  Project: Research project

  • Epidermolysis bullosa 100%
  • Data Base 50%

• Langerhans cell and CD103+dDC in humoral response

  Kaplan, D. H. & Yao, C.

  AMERICAN ASSOCIATION OF IMMUNOLOGISTS

  10/1/14 → 9/30/15

  Project: Research project

• Keratinocytes control Langerhans cell migration by spati

  Shaik, J.

  DERMATOLOGY FOUNDATION

  7/1/14 → 6/30/17

  Project: Research project

  • Langerhans Cell 100%
  • Keratinocyte 100%
  • Cell Migration 100%

• Humoral responses initiated by skin dendritic cells

  Igyarto, B. Z.

  AMERICAN SKIN ASSOCIATION

  7/1/14 → 6/30/15

  Project: Research project

  • Skin 100%
  • Humoral Immunity 100%
  • Dendritic Cell 100%

• A Phase 2, Multicenter, Randomized, Double-Blind, Contro

  Hordinsky, M. K.

  INTREPID THERAPEUTICS, INC

  5/27/14 → 12/31/16

  Project: Research project

  • Amaurosis 100%
  • Blindness 100%
  • Propionic Acid 50%
  • Minoxidil 50%
  • Cortodoxone 50%

• A randomized, double-blind, placebo-controlled, phase II

  Lee, P. K.

  GENENTECH, INC.

  10/23/13 → 12/31/15

  Project: Research project

  • Placebo 100%
  • Blindness 100%
  • Basal Cell Carcinoma 50%
  • Vismodegib 50%

• Anti-CK2 Therapy as a Novel Treatment for Cutaneous Squa

  Ahmed-Saucedo, R. L.

  WOMEN'S DERMATOLOGIC SOCIETY

  9/1/13 → 8/31/15

  Project: Research project

  • Combination Therapy 100%
  • Therapeutic Procedure 100%
  • Skin Carcinoma 50%

• Cannabinoid-based therapy and approaches to quantify pai

  Gupta, K., Bagchi, A., Connett, J. E., Ericson, M. E., He, B., Hebbel, R. P., Honda, C. N., Simone, D. A. & Ugurbil, K.

  NIH NAT'L HEART, LUNG, AND BLOOD INSTITU

  8/15/13 → 6/1/16

  Project: Research project

  • Combination Therapy 100%
  • Cannabinoid 100%
  • Sickle-Cell Disease 50%
  • Pain 50%
  • Sickle Cell Anemia 50%

• Therapeutic Reprogramming of Langerhans Cells

  Igyarto, B. Z.

  UNIVERSITY OF MINNESOTA FOUNDATION

  7/1/13 → 6/30/14

  Project: Research project

  • Reprogramming 100%
  • Langerhans Cell 100%

• Keratinocytes Control Homeostatic and Inflammation-induc

  Shaik, J.

  DERMATOLOGY FOUNDATION

  7/1/13 → 6/30/14

  Project: Research project

  • Inflammation 100%
  • Keratinocyte 100%
  • Langerhans Cell 50%
  • Cell Migration 50%

• An Open-label, Proof of Concept Study of Gevokizumab in

  Bohjanen, K. A.

  XOMA CORPORATION

  6/15/13 → 6/15/14

  Project: Research project

  • Gevokizumab 100%
  • Pyoderma gangrenosum 50%

• A Prospective Observational Study of Treatment Patterns

  Bohjanen, K. A. & Lee, P. K.

  GENENTECH, INC.

  6/3/13 → 6/30/20

  Project: Research project

  • Therapeutic Procedure 100%
  • Observational Study 100%
  • Basal-Cell Carcinoma 50%
  • Nevus Sebaceous 50%
  • Patient 50%

• A PROSPECTIVE OBSERVATIONAL STUDY OF TREATMENT PATTERNS

  Bohjanen, K. A. & Lee, P. K.

  GENENTECH, INC.

  6/3/13 → 6/30/20

  Project: Research project

  • Therapeutic Procedure 100%
  • Observational Study 100%
  • Basal-Cell Carcinoma 50%
  • Nevus Sebaceous 50%
  • Patient 50%

• Keratinocytes Control Homeostatic and Inflammation-induc

  Shaik, J.

  AMERICAN SKIN ASSOCIATION

  1/1/13 → 12/31/13

  Project: Research project

  • Inflammation 100%
  • Keratinocyte 100%
  • Langerhans Cell 50%
  • Cell Migration 50%